Published in Hepatitis Weekly, July 29th, 1996
Hepatitis C virus (HCV) infection becomes chronic in the majority of patients, and serious long-term consequences such as liver cirrhosis and hepatocellular carcinoma are eventually seen in some of these patients.
Interferon alpha (IFN-(alpha)) treatment induces a biochemical response in approximately 50 percent of patients with chronic HCV, which is sustained after discontinuation of IFN treatment in half of the responders, usually accompanied by disappearance of HCV RNA from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.